Study Group: Pediatric Dermatologists(?)
Council Members in this Study Group: 64
Request a survey with this Study Group
Related Study Groups
| Study Group Name | Members |
|---|---|
| Dermatologists (US) | 591 |
| Cosmetic Dermatologists | 334 |
| Cosmetic Dermatologists (US) | 264 |
| Hair Restoration Dermatologists (US) | 268 |
| Physicians who Treat Acne (US) | 289 |
| Cosmetic Dermatologists in Private Practice (US) | 174 |
| Dermatologists (EU) | 199 |
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
Drysport has equivalent safety and efficacy data abroad to currently available Botox. A less expensive price point is anticipated.
Injections of botulinum toxin type A were the number one non-surgical procedure in 2006, with over 3 million total procedures. Retail U.S. aesthetic market of approximately $300 million-$400 million. "Revance's proprietary drug delivery technology."
This treatment is run illegally, in violation of FDA laws Additionally, it is outlawed in Europe, Canada and Brazil, among other places Lastly, it isn't all that effective, from what I hear, and very painful. In summary, better options will become available.
+ Novel antimicrobial barrier will have broad implications for both prophylaxis post-operatively as well as for dermatologic conditions that are suceptible to superinfection (i.e. atopic dermatitis)
+ Recurrence rates for outdated lasers are a mute point. + The current generation of lasers for vascular lesions are standard of care and deliver as promised.
Most Common Company Types:
- Academic Medical Center/Hospital or Clinic
- Office Based Private Practice or Clinic
- Non-Academic Community Hospital or Clinic
- Academic Institution*
Most Common Job Types:
- Physician - Attending Physician
- Owner
- Physician - Director
- Physician - Division Head
- Partner
- Medical Director
- Physician - Department Chair